CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
PENG block with 0.25% bupivacaine.drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06166602
NCT06166602N/ACompleted

Comparison of the Impacts of Ultrasound-guided Pericapsular Nerve Group (PENG) Block Applied in Different Volumes on Postoperative Pain in Hip Replacement Surgeries: A Randomized Clinical Trial

Istanbul Medeniyet University·interventional·Posted Dec 12, 2023·Updated May 11, 2026

In Brief

A clinical study evaluating PENG block with 0.25% bupivacaine. for Regional Anesthesia and 2 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

Postoperative pain management has an important place in anesthesia practices. In order to ensure patient comfort after the surgery, to start postoperative rehabilitation early, and to prevent the process from causing mood disorders such as anxiety and pathological conditions such as chronic pain syndrome, the pain caused by the operation in the postoperative period must be effectively relieved. Pericapsular nerve group (PENG) block; It is a regional anesthesia technique that targets the anterior capsule of the hip joint and aims to block the joint branches of the accessory obturator nerve and femoral nerve by administering local anesthetic. Although it has been described recently, controlled prospective studies in the literature have shown it to be a safe and effective regional technique for postoperative pain after hip surgery. However, volume studies on this block are limited. Therefore, in this study, we aimed to determine the optimal dose by comparing the effectiveness of PENG block on pain using different local anesthetic volumes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedDec 12, 2023
Enrollment StartJul 30, 2023
Primary CompletionDec 20, 2023
Study CompletionDec 22, 2023
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.6 years ago

Interventions

PENG block with 0.25% bupivacaine.drug

Peng block will be applied to the same side as the surgery, using 0.25% bupivacaine at the same concentration in different volumes.